Company / Current Assets per Share
Revolution Medicines, Inc. Current Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$11.16
FY2025
5-year range
$8.86 / $20.79
FY2021-FY2025
Trend
-21.0%
vs FY2024
Sector context
#68 of 210
Health Care
What the data says
At $11.16, Revolution Medicines, Inc.'s current assets per share ranks #68 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 7 years, ranging from $8.86 in FY2021 to $137.94 in FY2020.
Based on SEC 10-K filings.
11.16 in FY2025 with a 5-year CAGR of -39.5%.
Declined from $20.79 to $11.16 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +7.8%
- 5-Year CAGR
- -39.5%
- 10-Year CAGR
- -
Sector benchmark
#68 of 210 in Health CareTop 32% of 210This company $11.16 Sector average $134.38
▼
-91.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 21.0% year-over-year.
- Ranks #68 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.16 | -21.0% |
| FY2024 | $14.13 | -32.0% |
| FY2023 | $20.79 | +133.4% |
| FY2022 | $8.90 | +0.6% |
| FY2021 | $8.86 | -93.6% |
| FY2020 | $137.94 | +185.5% |
| FY2019 | $48.32 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026